$ATYR aTyr Pharma Rebounding! 🚀 Up 32% 🔹 Big move after the company gave a regulatory update on efzofitimod for pulmonary sarcoidosis 📈 🔹 aTyr plans to keep

$ATYR aTyr Pharma Rebounding! 🚀 Up 32% 🔹 Big move after the company gave a regulatory update on efzofitimod for pulmonary sarcoidosis 📈 🔹 aTyr plans to keep development moving after FDA Type C Meeting feedback 🔥 🔹 Company expects to submit an IND in June 2026 for a new Phase 3 study 💡 🔹 Efzo…